ArticleCell death & disease2025

Synergistic antitumor activity of sorafenib and the NUPR1 inhibitor LZX-2-73 in multiple cancer models.

Xi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.